Health economic evaluations and Health Technology Assessment are increasingly used in decisions on market access for medicines and medtech solutions. But market access does not automatically mean patient access. In order to enable patients to benefit from truly innovative medicines and medtech solutions, also clinicians need to understand their value and value for money.
In this webinar, dated 29 November 2021, Prof. Lieven Annemans, faculty member of CELforPharma's courses on the Fundamentals of Health Economics and Health Technology Assessment, provides his insights as to what the principles and methods of health economic evaluations mean for clinicians and patients:
How to talk about value for money
How to align clinical & economic perspectives
How to deal with evidence gaps
PS: You will only have to submit your email address, name and company, after clicking on the video to watch this webinar.
Learn more about this topic at the following short duration course(s):
Health Economics for Non-Health-Economists
By Prof. Dr. Lieven Annemans
Online Self-Study Programme: Basics of Health Economics
By Prof. Dr. Lieven Annemans
How to Optimally Manage HTA Criteria & Processes in Europe
By Prof. Dr. Lieven Annemans